{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:23:44Z","timestamp":1790792624623,"version":"4.1.0"},"reference-count":42,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia","award":["RSPD2023R944"],"award-info":[{"award-number":["RSPD2023R944"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Ruxolitinib (RUX) is a potent drug that has been approved by the Food and Drug Administration for the treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease. This study describes the formation of colored charge-transfer complexes (CTCs) of RUX, an electron donor, with chloranilic acid (CLA) and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), the \u03c0-electron acceptors. The CTCs were characterized using UV-visible spectrophotometry. The formation of CTCs in methanol was confirmed via formation of new absorption bands with maximum absorption at 530 and 470 nm for CTCs with CLA and DDQ, respectively. The molar absorptivity and other physicochemical and electronic properties of CTCs were determined. The molar ratio was found to be 1:1 for both CTCs with CLA and CTCs with DDQ. The site of interaction on RUX molecules was assigned and the mechanisms of the reactions were postulated. The reactions were employed as basis for the development of a novel green and one-step microwell spectrophotometric method (MW-SPM) for high-throughput quantitation of RUX. Reactions of RUX with CLA and DDQ were carried out in 96-well transparent plates, and the absorbances of the colored CTCs were measured by an absorbance microplate reader. The MW-SPM was validated according to the ICH guidelines. The limits of quantitation were 7.5 and 12.6 \u00b5g\/mL for the methods involving reactions with CLA and DDQ, respectively. The method was applied with great reliability to the quantitation of RUX content in Jakavi\u00ae tablets and Opzelura\u00ae cream. The greenness of the MW-SPM was assessed by three different metric tools, and the results proved that the method fulfills the requirements of green analytical approaches. In addition, the one-step reactions and simultaneous handling of a large number of samples with micro-volumes using the proposed method enables the high-throughput analysis. In conclusion, this study describes the first MW-SPM, a valuable analytical tool for the quality control of pharmaceutical formulations of RUX.<\/jats:p>","DOI":"10.3390\/molecules28237877","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T09:39:12Z","timestamp":1701337152000},"page":"7877","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Spectrophotometric Study of Charge-Transfer Complexes of Ruxolitinib with Chloranilic Acid and 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone: An Application to the Development of a Green and High-Throughput Microwell Method for Quantification of Ruxolitinib in Its Pharmaceutical Formulations"],"prefix":"10.3390","volume":"28","author":[{"given":"Khalid A.","family":"Aljaber","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-623X","authenticated-orcid":false,"given":"Ibrahim A.","family":"Darwish","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Al-Hossaini","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1182\/blood.V120.21.5061.5061","article-title":"Ruxolitinib in Clinical Practice for Therapy of Myelofibrosis: Single USA Center Experience After FDA Approval","volume":"120","author":"Geyer","year":"2012","journal-title":"Blood"},{"key":"ref_2","unstructured":"FDA. U.S. Food & Drug Administration (2023, October 07). FDA Approves Treatment for Patients with Rare Bone Marrow Disorder, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-treatment-patients-rare-bone-marrow-disorder."},{"key":"ref_3","unstructured":"(2023, October 07). Jakavi (ruxolitinib) Tablets [Highlights of Prescribing Information]. Wilmington, DE: Incyte Corporation, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/202192lbl.pdf."},{"key":"ref_4","unstructured":"FDA. U.S. Food & Drug Administration (2023, October 07). FDA Approves Ruxolitinib for Acute Graft-Versus-Host Disease, Available online: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-ruxolitinib-acute-graft-versus-host-disease."},{"key":"ref_5","unstructured":"FDA. U.S. Food & Drug Administration (2023, October 07). FDA Approves Ruxolitinib for Chronic Graft-Versus-Host Disease, Available online: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-ruxolitinib-chronic-graft-versus-host-disease#:~:text=On%20September%2022%2C%202021%2C%20the,patients%2012%20years%20and%20older."},{"key":"ref_6","unstructured":"FDA. U.S. Food & Drug Administration (2023, October 07). FDA Approves Topical Treatment Addressing Repigmentation in Vitiligo in Patients Aged 12 and Older, Available online: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-topical-treatment-addressing-repigmentation-vitiligo-patients-aged-12-and-older."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4065\/mcp.2011.0518","article-title":"Serious adverse events during ruxolitinib treatment discontinuation in patients with myelofibrosis","volume":"86","author":"Tefferi","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Di Michele, A., Schoubben, A., Varfaj, I., D\u2019Arpino, A., Mercolini, L., Sardella, R., Ricci, M., and Tiacci, E. (2020). Improved achiral and chiral HPLC-UV analysis of ruxolitinib in two different drug formulations. Separations, 7.","DOI":"10.3390\/separations7030047"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.22159\/ijpps.2023v15i2.46839","article-title":"Stability indicating analytical method development and validation for the estimation of ruxolitinib in bulk and pharmaceutical dosage form using UPLC","volume":"15","author":"Tabassum","year":"2023","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5530\/phm.2019.2.10","article-title":"A new stability indicating high performance liquid chromatography method for the estimation of ruxolitinib in bulk and tablet dosage form","volume":"10","author":"Biswal","year":"2019","journal-title":"Pharm. Methods"},{"key":"ref_11","first-page":"223","article-title":"A novel RP-HPLC method for the quantification of ruxolitinib in formulations","volume":"2","author":"Satyanarayana","year":"2012","journal-title":"J. Atoms Mol."},{"key":"ref_12","first-page":"10020","article-title":"Novel microwell-based spectrofluorimetric method assisted with fluorescence plate reader for determination of ruxolitinib: Optimization by response surface methodology and application to in-vitro drug release, content uniformity testing and analysis of urine","volume":"7","author":"Darwish","year":"2023","journal-title":"Talanta Open"},{"key":"ref_13","unstructured":"Wang, P.G. (2019). High-Throughput Analysis in the Pharmaceutical Industry, CRC Press. [1st ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/acs.oprd.9b00140","article-title":"The evolution of high-throughput experimentation in pharmaceutical development and perspectives on the future","volume":"23","author":"Mennen","year":"2019","journal-title":"Org. Process Res. Dev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1039\/C9RE00234K","article-title":"High throughput analysis enables high throughput experimentation in pharmaceutical process research","volume":"4","author":"Welch","year":"2019","journal-title":"React. Chem. Eng."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1134\/S1061934816090094","article-title":"A.A. J. Green analytical chemistry: Opportunities for pharmaceutical quality control","volume":"71","author":"Eldin","year":"2019","journal-title":"Anal. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Koel, M., and Kaljurand, M. (2019). Green Analytical Chemistry, Royal Society of Chemistry. [2nd ed.].","DOI":"10.1039\/9781839168864"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"26686","DOI":"10.1039\/C5RA00358J","article-title":"Green chemistry approaches as sustainable alternatives to conventional strategies in the pharmaceutical industry","volume":"5","author":"Gupta","year":"2015","journal-title":"RSC Adv."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhang, W., and Cue, B.W. (2012). Green Techniques for Organic Synthesis and Medicinal Chemistry, John Wiley & Sons, Ltd.","DOI":"10.1002\/9780470711828"},{"key":"ref_20","first-page":"43","article-title":"Microplate-based assays: The future of pharmaceutical analysis","volume":"85","author":"Liu","year":"2016","journal-title":"Trends Anal. Chem."},{"key":"ref_21","first-page":"203","article-title":"Microwell spectrophotometry: A green analytical technique for pharmaceutical analysis","volume":"7","author":"Singh","year":"2017","journal-title":"J. Pharm. Anal."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1039\/C4GC01563K","article-title":"Overcoming barriers to green chemistry in the pharmaceutical industry\u2014The Green Aspiration Level\u2122 concept","volume":"17","author":"Roschangar","year":"2015","journal-title":"Green Chem."},{"key":"ref_23","first-page":"12","article-title":"Green analytical chemistry: Integration of renewable energy and green separation approaches","volume":"115","author":"Huang","year":"2019","journal-title":"Trends Anal. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Darwish, I.A., and Alzoman, N.Z. (2023). Development and validation of green and high-throughput microwell spectrophotometric assay for the determination of selective serotonin reuptake inhibitors in their pharmaceutical dosage forms. Molecules, 28.","DOI":"10.3390\/molecules28104221"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.3390\/molecules28104049","article-title":"Development of green and high throughput microplate reader-assisted universal microwell spectrophotometric assay for direct determination of tyrosine kinase inhibitors in their pharmaceutical formulations irrespective the diversity of their chemical structures","volume":"28","author":"Darwish","year":"2023","journal-title":"Molecules"},{"key":"ref_26","unstructured":"Breslin, J.W., Gaudreault, N., and Watson, K.D. (2011). A novel high-throughput assay for screening of anti-angiogenic agents using micro-plate-based culturing of endothelial cells. BMC Biotechnol., 11."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"G\u00f6r\u00f6g, S. (2018). Ultraviolet-Visible Spectrophotometry in Pharmaceutical Analysis, CRC Press.","DOI":"10.1201\/9781351077422"},{"key":"ref_28","unstructured":"Ahmed, S., Rasul, A., and Masood, Z. (2011). Spectrophotometry in Pharmaceutical Analysis, LAP Lambert Academic Publishing."},{"key":"ref_29","unstructured":"McCleverty, J.A., and Meyer, T.J. (2016). Handbook on the Physics and Chemistry of Rare Earths, Elsevier."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100644","DOI":"10.1016\/j.mtener.2021.100644","article-title":"Charge-transfer complexes and their applications in optoelectronic devices","volume":"20","author":"Shen","year":"2021","journal-title":"Materials Today Energy"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/medicina59040775","article-title":"Spectrophotometric investigations of charge transfer complexes of tyrosine kinase inhibitors with iodine as a \u03c3-electron acceptor: Application to development of universal high-throughput microwell assay for their determination in pharmaceutical formulations","volume":"59","author":"Darwish","year":"2023","journal-title":"Medicina"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.saa.2005.02.005","article-title":"Spectrophotometric and electrical studies of charge transfer complexes of 2-amino-1,3,4-thiadiazole with pi-acceptors","volume":"62","author":"Gaber","year":"2005","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"123537","DOI":"10.1016\/j.jhazmat.2020.123537","article-title":"Charge transfer complexes: Emerging and promising colorimetric real-time chemosensors for hazardous materials","volume":"103","author":"Shakya","year":"2021","journal-title":"J. Hazadous Mater."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1155\/2000\/831496","article-title":"Proton transfer equilibria, temperature and substituent effects on hydrogen bonded complexes between chloranilic acid and anilines","volume":"14","author":"Gohar","year":"2000","journal-title":"Spectrosco"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Darwish, I.A., Almehizia, A.A., Sayed, A.Y., Khalil, N.Y., Alzoman, N.Z., and Darwish, H.W. (2022). Synthesis, spectroscopic and computational studies on hydrogen bonded charge transfer complex of duvelisib with chloranilic acid: Application to development of novel 96-microwell spectrophotometric assay. Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 264.","DOI":"10.1016\/j.saa.2021.120287"},{"key":"ref_36","unstructured":"Fan, F. (2023). Band Gap, Encyclopedia Britannica. Available online: https:\/\/www.britannica.com\/science\/band-gap."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/ja01176a030","article-title":"A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons","volume":"71","author":"Benesi","year":"1949","journal-title":"J. Am. Soc."},{"key":"ref_38","first-page":"113","article-title":"Formation and stability of inorganic complexes in solution","volume":"9","author":"Job","year":"1928","journal-title":"Ann. Chem."},{"key":"ref_39","unstructured":"ICH (2022). ICH Harmonised Guideline, ICH. Validation of Analytical Procedure: Q2(R2)."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","article-title":"Analytical eco-scale for assessing the greenness of analytical procedures","volume":"37","author":"Konieczka","year":"2012","journal-title":"Trends Anal. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index","volume":"181","year":"2018","journal-title":"Talanta"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE-analytical greenness metric approach and software","volume":"92","author":"Wojnowski","year":"2020","journal-title":"Anal. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/23\/7877\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:35:08Z","timestamp":1760132108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/23\/7877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":42,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["molecules28237877"],"URL":"https:\/\/doi.org\/10.3390\/molecules28237877","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]}}}